Target Audience The educational design of this activity addresses the needs of Basic Science Researchers, Neuro-Oncologist, Neurosurgeons, Statisticians, Nurse Practitioners, Registered Nurses, Pharmacists, Allied Health Professionals involved in the treatment of patients with neuro-oncology.
Statement of Need/Program Overview The Society for Neuro- Oncology’s Annual Meeting is the largest and most influential meeting for multidisciplinary collaboration in the field of neuro-oncology. The latest advances in Central Nervous System (CNS) cancers are shared with an international audience that includes a variety of sub-specialties involved in basic & translational research, clinical as well as symptom management research. The meeting fosters opportunities to explore collaborations that will positively influence outcomes for patients with CNS cancers. This activity will be a collaboration of researchers and clinicians disseminating new knowledge to healthcare professionals in order to provide the highest quality of patient care to improve patient outcomes. The goal is to provide healthcare professionals with updated viewpoints, strategies, collaboration opportunities and an increased knowledge base to maximize treatment and management of brain tumor patients.
This year’s meeting will highlight the Vision for the Future of Neuro-Oncology. The pillars of the meeting will be on harnessing the use of biomarkers, tumor resistance, big data analysis, Immunotherapy, and COVID-19 and the impact on ongoing treatment. It is hoped that healthcare professionals will advance the treatment and management of CNS tumor patients.
The purpose of this conference is to provide those interested in the treatment and care of brain tumor patients with updated viewpoints and treatment strategies. Viewpoints and strategies include information on COVID, Immunotherapy, tumor resistance, and biomarkers.
Educational Objectives After completing this activity, the participant should be better able to:
Explain how to assess the mechanism of resistance to brain tumor therapy when determining strategies for novel therapeutic treatment options for patients.
Indicate how to incorporate biomarkers as an important component when selecting optimal treatment strategies for patients with tumors.
Explain how big data is gathered and the various algorithms used.
Describe how to apply big data outcomes to optimal patient care in the clinical setting.
Cite new advances in immunotherapy for brain tumor use.
Faculty Please click here for the list of speakers.
Physician Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians.
* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 20.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Please find the disclosures of all individuals in control of content for the program by clicking here.
Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Society for Neuro-Oncology do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Global Contact Information For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.